Identification S100A9 as a potential biomarker in neuroblastoma.
Xian ChenYukun XueJiao FengQingwu TianYunyuan ZhangQing WangPublished in: Molecular biology reports (2021)
Taken together, our findings suggested that S100A9 could participate in NB tumorigenesis and progression. In addition, S100A9 has the potential to be used as a promising clinical biomarker in the prediction of NB metastasis.